...Inc. (NASDAQ:BTAI) hired Javier Rodriguez as chief legal officer. He was chief legal officer at Indivior plc...

...and distribution costs. Controversy over Orphan exclusivity for opioid use disorder therapy Sublocade buprenorphine from Indivior plc...
...revoked the drug’s Orphan status after finding that its initial decision was “erroneous.” Steve Usdin, Washington Editor Indivior plc U.S...

...a recent controversy over Orphan exclusivity for an opioid use disorder therapy Sublocade buprenorphine from Indivior plc...

...Scott Olsen following his retirement, effective January. She is VP of global government affairs at Indivior plc...

...Ponni Subbiah as SVP, global head of medical affairs and CMO. She was CMO at Indivior plc...

...SEC filing Columbia will receive a six-digit license fee and is eligible for single-digit royalties. Indivior plc...

...sublingual film. Wednesday's move translates to a market cap loss of £551.9 million ($721.9 million). Indivior plc...
...11 patents related to Suboxone buprenorphine/naloxone sublingual film. The DOJ alleges in the indictment that Indivior...
...companies have launched generic versions in the U.S., in addition to Indivior's own authorized generic. Indivior...

...launched in the U.S. generic versions of opioid dependence drug Suboxone buprenorphine/naloxone sublingual film from Indivior plc...
...denying Indivior's motion to restrict Dr. Reddy's from launching its generic to the U.S. market. Indivior...
...Market Opioid Dependence Generic" ). Indivior reported $1.1 billion in 2018 U.S. sales of Suboxone. Indivior plc...

...so that Indivior can focus on long-term growth of its extended release injectable drug formulations. Indivior...
...4Q19. Indivior plc (LSE:INDV), Richmond, Va. Zhejiang Pukang Biotechnology Co. Ltd., Hangzhou, China Business: Neurology Hongjiang Li Suboxone, buprenorphine/naloxone Indivior plc Zhejiang...

...through November 2020 that was granted to opioid use disorder drug Sublocade subcutaneous buprenorphine from Indivior plc...
...to SEK66.90 on Dec. 28. Its shares did not trade Dec. 24 through Dec. 26. Indivior...
...Brixadi buprenorphine (CAM2038) Business: Neurology Sandi Wong CAM2038, buprenorphine Sublocade (Brand), RBP-6000 (Compound #), buprenorphine (Generic) Braeburn Pharmaceuticals Inc. Camurus AB Indivior plc Addiction Brixadi Buvidal opioid...